Skip to main content
Erschienen in: Pediatric Cardiology 7/2016

09.06.2016 | Original Article

Early Postoperative Albumin Administration Contributes to Morbidity After the Fontan Operation

verfasst von: Hayden J. Zaccagni, Jeffrey A. Alten, David C. Cleveland, R. Tyler Argent, Mark A. Law, Ayesha S. Bryant, Santiago Borasino

Erschienen in: Pediatric Cardiology | Ausgabe 7/2016

Einloggen, um Zugang zu erhalten

Abstract

The Fontan operation has low mortality, but is associated with significant postoperative morbidity, including prolonged chest tube output (PCTO), which is associated with prolonged hospital length of stay (PLOS). We sought to identify variables present early in the clinical course that could predict patients at high risk for PCTO and PLOS. Retrospective data were collected on 84 Fontan (extracardiac conduit) operations from 1/2008 to 12/2013 at a single institution. PCTO was defined as ≥8 days (>75th percentile); PLOS was defined as ≥12 days postoperatively (>75th percentile). Multivariate regression was used to determine covariates associated with PCTO and PLOS. Median age was 3.5 years (IQR 3–5); weight was 14.5 kg (IQR 13–17). There was no mortality. LOS was 9 days (IQR 3–11), and duration of chest tube drainage 6 days (IQR 5–8) at 15 ml/kg/day (IQR 9–20). In univariate analysis, only systemic right ventricle, 24-h 5 % albumin administration, 24-h fluid balance, and 12-h inotrope score were associated with PCTO. In multivariate analysis, only 5 % albumin administration in first 24 h (p < 0.001) and PCTO were independently associated with PLOS. ROC curve analysis showed patients receiving >25 ml/kg of 5 % albumin in first 24-h predicted PLOS (94 % specificity, 93 % sensitivity, AUC = 0.95, p < 0.001). Increased colloid in the first 24-h post-CPB strongly predicts PCTO and PLOS after Fontan operation, potentially providing an early identification of a cohort with unfavorable Fontan physiology. A better understanding of the role of colloid resuscitation after Fontan is necessary, and efforts to reduce perioperative colloid administration could decrease hospital morbidity
Literatur
1.
Zurück zum Zitat d’Udekem Y, Iyengar AJ, Cochrane AD, Grigg LE, Ramsay JM, Wheaton GR, Penny DJ, Brizard CP (2007) The Fontan procedure: contemporary techniques have improved long-term outcomes. Circulation 116(11 Suppl):I157–I164PubMed d’Udekem Y, Iyengar AJ, Cochrane AD, Grigg LE, Ramsay JM, Wheaton GR, Penny DJ, Brizard CP (2007) The Fontan procedure: contemporary techniques have improved long-term outcomes. Circulation 116(11 Suppl):I157–I164PubMed
2.
Zurück zum Zitat Van Arsdell GS, McCrindle BW, Einarson KD, Lee KJ, Oag E, Caldarone CA, Williams WG (2000) Interventions associated with minimal Fontan mortality. Ann Thorac Surg 70:568–574CrossRefPubMed Van Arsdell GS, McCrindle BW, Einarson KD, Lee KJ, Oag E, Caldarone CA, Williams WG (2000) Interventions associated with minimal Fontan mortality. Ann Thorac Surg 70:568–574CrossRefPubMed
3.
Zurück zum Zitat Gentles TL, Mayer JE Jr, Gauvreau K, Newburger JW, Lock JE, Kupferschmid JP, Burnett J, Jonas RA, Castaneda AR, Wernovsky G (1997) Fontan operation in five hundred consecutive patients: factors influencing early and late outcome. J Thorac Cardiovasc Surg 114:376–391CrossRefPubMed Gentles TL, Mayer JE Jr, Gauvreau K, Newburger JW, Lock JE, Kupferschmid JP, Burnett J, Jonas RA, Castaneda AR, Wernovsky G (1997) Fontan operation in five hundred consecutive patients: factors influencing early and late outcome. J Thorac Cardiovasc Surg 114:376–391CrossRefPubMed
4.
Zurück zum Zitat Lemler MS, Scott WA, Leonard SR, Stromberg D, Ramaciotti C (2002) Fenestration improves clinical outcome of the fontan procedure: a prospective, randomized study. Circulation 105:207–212CrossRefPubMed Lemler MS, Scott WA, Leonard SR, Stromberg D, Ramaciotti C (2002) Fenestration improves clinical outcome of the fontan procedure: a prospective, randomized study. Circulation 105:207–212CrossRefPubMed
5.
Zurück zum Zitat Fu S, Feng ZC, Dietmar S (2010) Factors influencing pleural effusion after Fontan operation: an analysis with 95 patients. Chin Med Sci J 25:38–43CrossRefPubMed Fu S, Feng ZC, Dietmar S (2010) Factors influencing pleural effusion after Fontan operation: an analysis with 95 patients. Chin Med Sci J 25:38–43CrossRefPubMed
6.
Zurück zum Zitat Gupta A, Daggett C, Behera S, Ferraro M, Wells W, Starnes V (2004) Risk factors for persistent pleural effusions after the extracardiac Fontan procedure. J Thorac Cardiovasc Surg 127:1664–1669CrossRefPubMed Gupta A, Daggett C, Behera S, Ferraro M, Wells W, Starnes V (2004) Risk factors for persistent pleural effusions after the extracardiac Fontan procedure. J Thorac Cardiovasc Surg 127:1664–1669CrossRefPubMed
7.
Zurück zum Zitat Mascio CE, Wayment M, Colaizy TT, Mahoney LT, Burkhart HM (2009) The modified Fontan procedure and prolonged pleural effusions. Am Surg 75:175–177PubMed Mascio CE, Wayment M, Colaizy TT, Mahoney LT, Burkhart HM (2009) The modified Fontan procedure and prolonged pleural effusions. Am Surg 75:175–177PubMed
8.
Zurück zum Zitat Fedderly RT, Whitstone BN, Frisbee SJ, Tweddell JS, Litwin SB (2001) Factors related to pleural effusions after Fontan procedure in the era of fenestration. Circulation 104:I148–I151CrossRefPubMed Fedderly RT, Whitstone BN, Frisbee SJ, Tweddell JS, Litwin SB (2001) Factors related to pleural effusions after Fontan procedure in the era of fenestration. Circulation 104:I148–I151CrossRefPubMed
9.
Zurück zum Zitat Atz AM, Travison TG, McCrindle BW, Mahony L, Quartermain M, Williams RV et al (2011) Late status of Fontan patients with persistent surgical fenestration. J Am Coll Cardiol 57:2437–2443CrossRefPubMedPubMedCentral Atz AM, Travison TG, McCrindle BW, Mahony L, Quartermain M, Williams RV et al (2011) Late status of Fontan patients with persistent surgical fenestration. J Am Coll Cardiol 57:2437–2443CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Gaynor JW, Bridges ND, Cohen MI, Mahle WT, Decampli WM, Steven JM et al (2002) Predictors of outcomes after the Fontan operation: is hypoplastic left heart syndrome still a risk factor? J Thorac Cardiovasc Surg 123:237–245CrossRefPubMed Gaynor JW, Bridges ND, Cohen MI, Mahle WT, Decampli WM, Steven JM et al (2002) Predictors of outcomes after the Fontan operation: is hypoplastic left heart syndrome still a risk factor? J Thorac Cardiovasc Surg 123:237–245CrossRefPubMed
11.
Zurück zum Zitat Shikata F, Yagihara T, Kagisaki K, Hagino I, Shiraishi S, Kobayashi J et al (2008) Does the off-pump Fontan procedure ameliorate the volume and duration of pleural and peritoneal effusions? Eur J Cardothorac Surg 34:570–575CrossRef Shikata F, Yagihara T, Kagisaki K, Hagino I, Shiraishi S, Kobayashi J et al (2008) Does the off-pump Fontan procedure ameliorate the volume and duration of pleural and peritoneal effusions? Eur J Cardothorac Surg 34:570–575CrossRef
12.
Zurück zum Zitat Pike NA, Okuhara MN, Toyama J, Gross BP (2015) Reduced pleural drainage, length of stay, and readmissions using a modified Fontan management protocol. J Thorac Cardiovasc Surg 150:481–487CrossRefPubMed Pike NA, Okuhara MN, Toyama J, Gross BP (2015) Reduced pleural drainage, length of stay, and readmissions using a modified Fontan management protocol. J Thorac Cardiovasc Surg 150:481–487CrossRefPubMed
13.
Zurück zum Zitat Hazle MA, Gajarski RJ, Sunkyung Y, Donohue J, Blatt NB (2013) Fluid overload in infants following congenital heart surgery. Pediatr Crit Care Med 14:44–49CrossRefPubMedPubMedCentral Hazle MA, Gajarski RJ, Sunkyung Y, Donohue J, Blatt NB (2013) Fluid overload in infants following congenital heart surgery. Pediatr Crit Care Med 14:44–49CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Goldberg DJ, French B, McBride MG, Marino BS, Mirarchi N, Hanna BD, Wenovsky G, Paridon SM, Rychik J (2011) Impact of oral sildenafil on exercise performance in children and young adults after the Fontan operation: a randomized, double-blind, placebo-controlled, crossover trial. Circulation 123:1185–1193CrossRefPubMedPubMedCentral Goldberg DJ, French B, McBride MG, Marino BS, Mirarchi N, Hanna BD, Wenovsky G, Paridon SM, Rychik J (2011) Impact of oral sildenafil on exercise performance in children and young adults after the Fontan operation: a randomized, double-blind, placebo-controlled, crossover trial. Circulation 123:1185–1193CrossRefPubMedPubMedCentral
Metadaten
Titel
Early Postoperative Albumin Administration Contributes to Morbidity After the Fontan Operation
verfasst von
Hayden J. Zaccagni
Jeffrey A. Alten
David C. Cleveland
R. Tyler Argent
Mark A. Law
Ayesha S. Bryant
Santiago Borasino
Publikationsdatum
09.06.2016
Verlag
Springer US
Erschienen in
Pediatric Cardiology / Ausgabe 7/2016
Print ISSN: 0172-0643
Elektronische ISSN: 1432-1971
DOI
https://doi.org/10.1007/s00246-016-1429-0

Weitere Artikel der Ausgabe 7/2016

Pediatric Cardiology 7/2016 Zur Ausgabe

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

26.04.2024 Mammografie Nachrichten

Routinemäßige Mammografien helfen, Brustkrebs frühzeitig zu erkennen. Anhand der Röntgenuntersuchung lassen sich aber auch kardiovaskuläre Risikopatientinnen identifizieren. Als zuverlässiger Anhaltspunkt gilt die Verkalkung der Brustarterien.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Adipositas-Medikament auch gegen Schlafapnoe wirksam

24.04.2024 Adipositas Nachrichten

Der als Antidiabetikum sowie zum Gewichtsmanagement zugelassene Wirkstoff Tirzepatid hat in Studien bei adipösen Patienten auch schlafbezogene Atmungsstörungen deutlich reduziert, informiert der Hersteller in einer Vorab-Meldung zum Studienausgang.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.